Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Abi Selvarajah"'
Autor:
Sem A.O.F. Rikken, Willem L. Bor, Abi Selvarajah, Kai L. Zheng, Amy P. Hack, C. Michael Gibson, Christopher B. Granger, Ohad S. Bentur, Barry S. Coller, Arnoud W.J. van ’t Hof, Jurriën M. ten Berg
Publikováno v:
American Heart Journal. 262:75-82
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::277c33e761c3ab3b3528e824b7c0055e
https://doi.org/10.1016/j.ahj.2023.04.009
https://doi.org/10.1016/j.ahj.2023.04.009
Autor:
Sem A O F, Rikken, Abi, Selvarajah, Renicus S, Hermanides, Barry S, Coller, C Michael, Gibson, Christopher B, Granger, Frédéric, Lapostolle, Sonja, Postma, Henri, van de Wetering, Risco C W, van Vliet, Gilles, Montalescot, Jurriën M, Ten Berg, Arnoud W J, van 't Hof, F, Zijlstra
Publikováno v:
American Heart Journal, 258, 119-128. MOSBY-ELSEVIER
BACKGROUND: Early and complete restoration of target vessel patency in ST-elevation myocardial infarction (STEMI) is associated with improved outcomes. Oral P2Y12 inhibitors have failed to demonstrate either improved patency or reduced mortality when
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4573a3799b4a684eb4db7f90949eb09
https://doi.org/10.1016/j.ahj.2022.12.015
https://doi.org/10.1016/j.ahj.2022.12.015
Autor:
Enrico Fabris, Abi Selvarajah, Annerieke Tavenier, Rik Hermanides, Elvin Kedhi, Gianfranco Sinagra, Arnoud van’t Hof
Publikováno v:
American Journal of Cardiovascular Drugs. 22:463-474
Antithrombotic therapy is the cornerstone of pharmacological treatment in patients undergoing primary percutaneous coronary intervention (PCI). However, the acute management of ST elevation myocardial infarction (STEMI) patients includes therapy for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4635ef2775518b199e4147c1b3d9799
https://doi.org/10.1007/s40256-022-00531-y
https://doi.org/10.1007/s40256-022-00531-y
Autor:
Abi Selvarajah, Anne H. Tavenier, Enrico Fabris, Maarten A. H. van Leeuwen, Renicus S. Hermanides
The pharmacological treatment strategies for acute coronary syndrome (ACS) in recent years are constantly evolving to develop more potent antithrombotic agents, as reflected by the introduction of more novel P2Y12 receptor inhibitors and anticoagulan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbdcbff31d6dbbe43d3771d0aea56805
https://hdl.handle.net/11368/3041339
https://hdl.handle.net/11368/3041339
Autor:
Jur ten Berg, Maarten A.H. van Leeuwen, Vital Houben, Abi Selvarajah, Wilbert Bor, Koen Teeuwen, Renicus S Hermanides, Erik Lipsic, Giovanni Amoroso, Sjoerd H. Hofma, Saman Rasoul, Eliza Kaplan, Annerieke H Tavenier, Arnoud W J van ‘t Hof
Publikováno v:
European Heart Journal Open. 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2dbbf0871fdecdfdaa59440797a9fe9d
https://doi.org/10.1093/ehjopen/oeab028
https://doi.org/10.1093/ehjopen/oeab028
Autor:
Abi, Selvarajah, Annerieke H, Tavenier, Wilbert L, Bor, Vital, Houben, Saman, Rasoul, Eliza, Kaplan, Koen, Teeuwen, Sjoerd H, Hofma, Erik, Lipsic, Giovanni, Amoroso, Maarten A H, van Leeuwen, Jur M, Ten Berg, Arnoud W J, van 't Hof, Renicus S, Hermanides
Publikováno v:
European heart journal open. 1(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0ba3be634bb3ad37f1663a637e360611
https://pubmed.ncbi.nlm.nih.gov/35923807
https://pubmed.ncbi.nlm.nih.gov/35923807